Stocks & Investing
Fri, October 4, 2024
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
[ Fri, Oct 04th 2024
] - WOPRAI
Thu, September 19, 2024
[ Thu, Sep 19th 2024
] - WOPRAI
[ Thu, Sep 19th 2024
] - WOPRAI
[ Thu, Sep 19th 2024
] - WOPRAI
Fri, September 6, 2024
[ Fri, Sep 06th 2024
] - WOPRAI
Tue, September 3, 2024
[ Tue, Sep 03rd 2024
] - WOPRAI
Thu, August 15, 2024
[ Thu, Aug 15th 2024
] - WOPRAI
Thu, August 8, 2024
[ Thu, Aug 08th 2024
] - WOPRAI
Tue, August 6, 2024
[ Tue, Aug 06th 2024
] - WOPRAI
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
Mon, July 29, 2024
[ Mon, Jul 29th 2024
] - WOPRAI
Wed, July 17, 2024
[ Wed, Jul 17th 2024
] - WOPRAI
Thu, June 27, 2024
[ Thu, Jun 27th 2024
] - WOPRAI
Wed, June 26, 2024
[ Wed, Jun 26th 2024
] - WOPRAI
Fri, June 21, 2024
[ Fri, Jun 21st 2024
] - WOPRAI
Tue, June 18, 2024
[ Tue, Jun 18th 2024
] - WOPRAI
Tue, June 11, 2024
[ Tue, Jun 11th 2024
] - WOPRAI
Wed, June 5, 2024
[ Wed, Jun 05th 2024
] - WOPRAI
Tue, June 4, 2024
[ Tue, Jun 04th 2024
] - WOPRAI
Wed, May 29, 2024
[ Wed, May 29th 2024
] - WOPRAI
Tue, May 28, 2024
[ Tue, May 28th 2024
] - WOPRAI
Tue, May 7, 2024
[ Tue, May 07th 2024
] - WOPRAI
Thu, April 11, 2024
[ Thu, Apr 11th 2024
] - WOPRAI
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
Tue, March 5, 2024
[ Tue, Mar 05th 2024
] - WOPRAI
Fri, March 1, 2024
[ Fri, Mar 01st 2024
] - WOPRAI
Thu, February 29, 2024
[ Thu, Feb 29th 2024
] - WOPRAI
Wed, February 14, 2024
[ Wed, Feb 14th 2024
] - WOPRAI
Brian Abrahams Maintained (SRPT) at Buy with Increased Target to $182 on, Oct 4th, 2024
Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $181 to $182 on, Oct 4th, 2024.
Brian has made no other calls on SRPT in the last 4 months.
There are 11 other peers that have a rating on SRPT. Out of the 11 peers that are also analyzing SRPT, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $152 on, Friday, September 20th, 2024
- David Hoang of "Citigroup" Maintained at Hold with Decreased Target to $160 on, Thursday, August 8th, 2024
These are the ratings of the 9 analyists that currently disagree with Brian
- Gavin Clark-Gartner of "Evercore ISI Group" Upgraded from Hold to Buy and Decreased Target to $179 on, Thursday, August 8th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $203 on, Thursday, August 8th, 2024
- Biren Amin of "Piper Sandler" Maintained at Buy with Decreased Target to $200 on, Thursday, August 8th, 2024
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $235 on, Thursday, June 27th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Mani Foroohar of "Leerink Partners" Maintained at Buy with Increased Target to $230 on, Monday, June 24th, 2024
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $213 on, Friday, June 21st, 2024
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, June 21st, 2024
